Search Results - "tyrosine kinase"

Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations by Katarzyna Malarz, Jacek Mularski, Marcin Pacholczyk, Robert Musiol

Connect to this object online.

Pharmacological Evidence for Involvement of Phospholipase D, Protein Kinase C, and Sodium-Calcium Exchanger in -Adrenoceptor-Mediated Negative Inotropy in Adult Mouse Ventricle by Kazuhide Nishimaru, Yoshio Tanaka, Hikaru Tanaka, Koki Shigenobu

Connect to this object online.

Rilzabrutinib-induced transition from <i>pemphigus vulgaris</i> to <i>pemphigus foliaceous</i>: case report and review of the literature by Christian Ciolfi, Jacopo Tartaglia, Francesca Pampaloni, Laura Fagotto, Andrea Sechi, Mauro Alaibac

Connect to this object online.

Epidermal growth factor receptor pathway as therapeutic development in head and neck cancers: present and future by Chancellor E. Donald, Luis E. Raez, Edgardo S. Santos

Connect to this object online.

Immunotherapy in renal cell carcinoma: latest evidence and clinical implications by Matteo Santoni, Francesco Massari, Vincenzo Di Nunno, Alessandro Conti, Alessia Cimadamore, Marina Scarpelli, Rodolfo Montironi, Liang Cheng, Nicola Battelli, Antonio Lopez-Beltran

Connect to this object online.

Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations by Wenliang Liu, Siying Ren, Ying Xiao, Lulu Yang, Chao Zeng, Yan Hu

Connect to this object online.

Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities by Flis S, Chojnacki T

Connect to this object online.

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells by Ahmad Hamad, Zeyad Sahli, Maya El Sabban, Maha Mouteirik, Rihab Nasr

Connect to this object online.

The role of dasatinib in the management of&nbsp;chronic myeloid leukemia by Chen R, Chen B

Connect to this object online.

Zanubrutinib in Treating Waldenström Macroglobulinemia, the Last Shall Be the First by Deshpande A, Munoz J

Connect to this object online.

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor by Singer J, Al-Fayoumi S, Ma H, Komrokji R, Mesa R, Verstovsek S

Connect to this object online.

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives by Costa R, Carneiro BA, Chandra S, Pai SG, Chae YK, Kaplan JB, Garrett HB, Agulnik M, Kopp PA, Giles FJ

Connect to this object online.

HPLC method development and validation for the estimation of axitinibe in rabbit plasma by Achanta Suneetha, Sharmila Donepudi

Connect to this object online.

Pharmacology and rationale for imatinib in the treatment of scleroderma by Moinzadeh P, Hunzelmann N, Krieg T

Connect to this object online.

The new concepts on overcoming drug resistance in lung cancer by Zhang W, Lei P, Dong X, Xu C

Connect to this object online.

The Difficulties of Differential Diagnosis of the Bronchial Obstruction Syndrome by I. V. Demko, M. G. Mamaeva, A. Yu. Kraposhina, E. A. Sobko, N. V. Gordeeva, S. A. Sidorov, V. V. Dyatlovskij

Connect to this object online.

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib by Rothschild SI

Connect to this object online.

Epidemiology, clinical characteristics and potential mechanism of ibrutinib-induced ventricular arrhythmias by Yilin Pan, Yilin Pan, Yanan Zhao, Hangyu Ren, Hangyu Ren, Xintong Wang, Caixia Liu, Beibei Du, Kumaraswamy Nanthakumar, Ping Yang

Connect to this object online.

The lysosome as a novel therapeutic target of EGFR-mediated tumor inflammation by Woo Jung Sung, Dohyang Kim, Anlin Zhu, Namki Cho, Hee Min Yoo, Hee Min Yoo, Ji Heon Noh, Kyoung Mi Kim, Hyun-Su Lee, Jaewoo Hong

Connect to this object online.

A case report of toxic epidermal necrolysis associated with AZD-9291 by Wang J, Cheng XY, Lu Y, Zhou BR

Connect to this object online.